MAIA Biotechnology Inc.

AMEX: MAIA · Real-Time Price · USD
1.57
0.01 (0.64%)
At close: Aug 15, 2025, 12:38 PM

MAIA Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-19.78M -18.43M -16.96M -18.33M -19.1M -19.95M -20.18M -19.1M -19.24M -18.02M -17.28M -14.98M -12.12M -10.18M -7.79M -8.13M -6.72M -5.22M
Interest Income
347.75K 356.43K 318.37K 269.31K 166.48K 78.27K 34.49K 4.39K 1.48K 1.73K 1.87K 1.76K 2.12K 2.34K 2.01K 23.32K 30.35K 29.69K
Pretax Income
-16.17M -19.7M -23.27M -25.98M -28.18M -23.87M -19.95M -18.78M -18.82M -17.56M -16.81M -14.58M -14.82M -14.97M -12.58M -13M -8.63M -5.17M
Net Income
-16.17M -19.7M -23.25M -25.94M -28.08M -23.72M -19.71M -18.57M -18.66M -17.44M -16.8M -14.58M -14.81M -14.93M -12.5M -12.9M -8.43M -5M
Selling & General & Admin
7.84M 7.55M 6.95M 7.57M 8.41M 8.71M 9.07M 8.21M 7.51M 6.77M 6.14M 5.83M 5.33M 4.87M 4.29M 5.58M 5.1M 4.24M
Research & Development
11.94M 10.89M 10.03M 10.8M 10.74M 11.28M 11.09M 9.42M 9.17M 8.69M 8.59M 8.02M 6.76M 5.28M 3.5M 2.55M 1.62M 976K
Other Expenses
-1K -1K n/a n/a n/a n/a n/a 1.16M 1.1M 1.1M 1.1M -65.11K n/a n/a n/a n/a n/a n/a
Operating Expenses
19.78M 18.43M 16.98M 18.38M 19.14M 19.95M 20.12M 18.93M 17.96M 16.65M 15.93M 13.71M 11.95M 10.15M 7.79M 8.08M 6.67M 5.17M
Interest Expense
85.00 85.00 85.00 85.00 n/a 1.72K 6.86K 12.01K 13.72K 12.11K 6.97K 1.82K 451.41K 764.77K 827.54K 827.54K 376.23K 62.77K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
19.77M 18.41M 16.96M 18.38M 19.08M 19.89M 20.06M 18.87M 17.9M 16.58M 15.86M 13.65M 11.95M 10.15M 7.79M 8.13M 6.72M 5.22M
Income Tax Expense
n/a n/a -18.6K -45.86K -107.57K -145.79K -189.42K -1.16M -63.45K -25.23K 6.82K 1M -30.18K -30.18K n/a 25.88K 25.88K 25.88K
Shares Outstanding (Basic)
30.3M 27.7M 26.16M 23.89M 22.2M 17.6M 16.99M 13.68M 12.88M 10.98M 9.28M 10.17M 10.22M 10.64M 10.64M 10.64M 10.64M 10.64M
Shares Outstanding (Diluted)
30.3M 27.7M 26.16M 23.89M 22.2M 17.6M 16.99M 13.68M 12.88M 10.98M 9.28M 10.17M 8.2M 10.64M 10.64M 10.64M 10.64M 10.64M
EPS (Basic)
-0.59 -0.81 -1.11 -1.34 -1.59 -1.54 -1.45 -1.52 -1.65 -1.62 -1.61 -1.44 -1.44 -1.44 -1.17 -1.21 -0.79 -0.47
EPS (Diluted)
-0.59 -0.81 -1.11 -1.34 -1.59 -1.54 -1.45 -1.52 -1.65 -1.62 -1.61 -1.44 -1.44 -1.44 -1.17 -1.21 -0.79 -0.47
EBITDA
-16.93M -20.66M -19.16M -21.82M -23.96M -19.59M -19.77M -16.67M -15.79M -14.57M -13.88M -13.61M -11.85M -10.04M -7.59M -4.64M -2.4M -896.23K
EBIT
-17.08M -20.61M -19.12M -21.8M -23.94M -19.59M -19.77M -18.62M -18.65M -17.43M -16.73M -14.52M -14.37M -14.21M -11.75M -12.2M -8.27M -5.12M
Depreciation & Amortization
6.85M 1.77M 291.93K 167K 3.67M 13.42M 13.65M 14.67M 14.81M 13.59M 12.85M 14.98M 12.12M 10.18M 7.79M 8.13M 6.72M 5.22M